ACAD vs AMRX
As of Sep 20, 2026, Acadia Pharmaceuticals (ACAD) scores 6.9/10 and Amneal Pharmaceuticals (AMRX) 6.9/10 on AlphaStocks' five-model composite, the same score. AMRX trades 81% above its model fair value.
ACAD
ACADIA PHARMACEUTICALS INC
6.9
Consider Buy
$27.27
AMRX
Amneal Pharmaceuticals, Inc.
6.9
Consider Buy
$18.70
ACAD vs AMRX: Which is the Better Investment?
ACADIA PHARMACEUTICALS INC (ACAD) scores 6.9/10 while Amneal Pharmaceuticals, Inc. (AMRX) scores 6.9/10 on AlphaStocks' composite model. Both stocks share the same composite score. On a P/E basis, ACADIA PHARMACEUTICALS INC trades at 11.8x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | ACAD | AMRX |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.9/10 | 6.9/10 |
| Rating | Consider Buy | Consider Buy |
| Price | $27.27 | $18.70 |
| P/E Ratio | 11.8▲ | 84.3 |
| ROE | 12.9%▲ | -80.0% |
| Market Cap | $5B | $6B |
| Fair Value | — | $10.31 |
| Dividend Yield | — | — |
| Sector Rank | #15 of 168▲ | #16 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Neutral | Neutral |
| Graham | Neutral | Neutral |
| Lynch | Limited Data | Attractive▲ |
| Greenblatt | Limited Data | Attractive▲ |
Related comparisons
ACAD vs AMRX: Which Stock Scores Higher?
ACADIA PHARMACEUTICALS INC (ACAD) and Amneal Pharmaceuticals, Inc. (AMRX) are both in the Health Care sector. Both stocks are closely matched with composite scores of 6.9/10.
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer